Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

diaDexus, Inc.: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

11 Apr 2014 Reuters Investment Profile 12 $20.00

DDXS- STABILITY data appears to back Lp-PLA2 as marker, reiterate STRONG BUY, $2.90PT

STABILITY data appears to back Lp-PLA2 as marker, reiterate STRONG BUY, $2.90PT

31 Mar 2014 Feltl & Company 7 $58.00

Wright Investors Service Comprehensive Report for Diadexus Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Mar 2014 Wright Reports 42 $75.00

diaDexus, Inc. (DDXS) - Financial Analysis Review

diaDexus, Inc. (DDXS) - Financial Analysis Review Summary diaDexus, Inc. (diaDexus) is a biotechnology company. The com...

07 Mar 2014 GlobalData 33 $125.00

DDXS- Q4 slightly ahead, 3 new tests licensed from TMO, reiterate STRONG BUY, $2.90 PT

Q4 slightly ahead, 3 new tests licensed from TMO, reiterate STRONG BUY, $2.90 PT

06 Mar 2014 Feltl & Company 11 $104.00

DDXS.PK - Event Transcript of diaDexus, Inc. conference call, Mar. 05, 2014 / 4:30PM ET

Edited Event Transcript of DDXS.PK conference call, Mar. 05, 2014 / 4:30PM ET Boston, Mar 11, 2014 (Thomson StreetEvent...

05 Mar 2014 Thomson Reuters StreetEvents 11 $75.00

diaDexus, Inc. (DDXS) - Financial Analysis Review

diaDexus, Inc. (DDXS) - Financial Analysis Review Summary diaDexus, Inc. (diaDexus) is a biotechnology company. The com...

29 Jan 2014 GlobalData 32 $125.00

diaDexus, Inc. (DDXS) - Medical Equipment - Deals and Alliances Profile

diaDexus, Inc. (DDXS) - Medical Equipment - Deals and Alliances Profile Summary diaDexus, Inc. (diaDexus) is a biotechnology ...

11 Dec 2013 GlobalData 28 $250.00

DDXS.PK - Event Transcript of diaDexus, Inc. conference call, Dec. 10, 2013 / 3:55PM ET

Edited Event Transcript of DDXS.PK conference call, Dec. 10, 2013 / 3:55PM ET New York, Dec 24, 2013 (Thomson StreetEve...

10 Dec 2013 Thomson Reuters StreetEvents 6 $75.00

DDXS- Darapladib study fails to meet primary endpoint, DDXS selloff overdone, reiterate SB

Darapladib study fails to meet primary endpoint, DDXS selloff overdone, reiterate SB

12 Nov 2013 Feltl & Company 8 $69.00